Conversations in High-Risk Non-Muscle Invasive Bladder Cancer
Immunotherapy Approaches in the Treatment of BCG-Naïve NMIBC Certified AMA/ANCC/ACPE Activity Conversations in High-Risk NMIBC is a roundtable discussion featuring a urologist and two oncologists. The expert faculty will detail and reflect on recent advances in the treatment and management of high-risk NMIBC. The activity will be supported by downloadable slides that have the key discussion and teaching points. FACULTY Matthew Galsky, MD Professor of Medicine Icahn School of Medicine at Mount Sinai Joshua Meeks, MD Associate Professor of Urology Northwestern University Abhishek Tripathi, MD Associate Professor, Department of Medical Oncology and Therapeutics Research City of Hope Medical Center Review one or all activities at https://bit.ly/3LuDc8q and claim AMA/ANCC/ACPE credit/contact hour after completion of a brief pretest and posttest/evaluation. This activity is provided in collaboration with Rush University Medical Center and Practice Point Communications Supported by an independent educational grant from AstraZeneca #freecme #bladdercancer #oncology #practicepointcme

Conversations in High-Risk Non-Muscle Invasive Bladder Cancer

Non-Muscle Invasive Bladder Cancer: Guidelines-Based Approach

What’s in the Pipeline for Bladder Cancer Management in 2026 with Seth P. Lerner, MD, FACS

Bladder Cancer Treatment Algorithm Discussion with Drs. Karine Tawagi and Sia Daneshmand

BCG Treatment for High Grade, Non-Muscle Invasive Bladder Cancer

Bladder Cancer Explained: Risk Factors, Symptoms & Treatment

Muscle Invasive Bladder Cancer

Bladder Cancer Risk Stratification: Moving from the Old to the New

Robin Williams Shaped a Generation

A Better Treatment than BCG for Bladder Cancer?

May 2026 - Research Spotlight with Dr. DeMayo and Dr. Sochet

Management of Non-Muscle Invasive Bladder Cancer

Bladder Cancer: NON-Muscle Invasive (Superficial Bladder Cancer)

Treating Carcinoma In-Situ in the Bladder

Clinical Tipping Points In Portal Hypertension Virtual Broadcast

Immunotherapy for Muscle Invasive Bladder Cancer

CIC May 2026 Seminar Series - Dr. Ambarish Pandey

4.17.2020 Urology COViD Didactics - BCG Unresponsive Bladder Cancer

Non-Muscle Invasive Bladder Cancer Treatment Dilemmas (2025)

